Key Takeaways
- • Private equity firms have established joint ventures across more than 500 healthcare facilities, representing a structurally different approach to healthcare market penetration compared to traditional outright acquisitions, according to a new report from the Private Equity Stakeholder Project (PESP).
- • Joint venture structures allow private equity to access nonprofit health systems' reputational assets, regulatory relationships, and patient bases while distributing financial risk across partners—a strategy that circumvents some of the scrutiny faced by pure acquisition plays like Steward Health Care and Prospect Medical Holdings.
- • Healthcare facilities operating under nonprofit-private equity joint ventures span multiple service lines including hospitals, inpatient rehabilitation, hospice, home health, behavioral health, ambulatory surgery centers, and urgent care—with the 500+ facility count likely understating actual prevalence due to limited public disclosure requirements.
- • Joint ventures enable private equity capital deployment with different regulatory treatment than traditional acquisitions, allowing firms to expand into new markets while leveraging nonprofit partners' operational and relational infrastructure without full consolidation risk.
Summary
Private equity's footprint in healthcare extends significantly beyond the high-profile hospital acquisitions and bankruptcies that have attracted regulatory and media scrutiny. A report from the Private Equity Stakeholder Project, a nonprofit advocacy organization focused on private equity transparency, reveals that more than 500 healthcare facilities currently operate under joint venture arrangements between private equity firms and nonprofit health systems—a lesser-known but structurally important strategy for market expansion.
Joint ventures differ materially from acquisition structures. They create a single shared enterprise in which participating parties contribute capital, labor, assets, skills, or knowledge and share control, profits, and losses according to negotiated terms. For private equity firms, this arrangement offers distinct advantages: access to nonprofit partners' established reputational standing, regulatory relationships, and patient networks without assuming full operational or financial liability. Simultaneously, joint ventures allow nonprofit health systems to pursue growth in specific service lines while maintaining institutional independence and sharing risk with well-capitalized partners.
The facilities operating under these arrangements span a diverse range of healthcare services—hospitals, inpatient rehabilitation centers, hospice operations, home health agencies, behavioral health providers, ambulatory surgery centers, and urgent care facilities. This diversification across service lines reflects private equity's strategic use of joint ventures to penetrate fragmented healthcare markets where traditional acquisition might trigger regulatory review or face community resistance. The PESP report explicitly notes that the 500+ facility count likely undercounts actual prevalence, as many joint ventures lack public disclosure requirements and remain identifiable only through targeted research.
The emergence of joint ventures as a primary private equity strategy in healthcare occurs within a context of heightened scrutiny of traditional acquisition models. Recent bankruptcies involving major private equity-backed health systems have prompted regulatory attention and policy discussions around financial risk concentration in healthcare. Joint ventures, by distributing risk and leveraging nonprofit governance structures, may face different regulatory pathways than pure private equity acquisitions, potentially allowing firms to achieve market expansion while operating in lower-visibility regulatory environments.
Joint ventures differ materially from acquisition structures. They create a single shared enterprise in which participating parties contribute capital, labor, assets, skills, or knowledge and share control, profits, and losses according to negotiated terms. For private equity firms, this arrangement offers distinct advantages: access to nonprofit partners' established reputational standing, regulatory relationships, and patient networks without assuming full operational or financial liability. Simultaneously, joint ventures allow nonprofit health systems to pursue growth in specific service lines while maintaining institutional independence and sharing risk with well-capitalized partners.
The facilities operating under these arrangements span a diverse range of healthcare services—hospitals, inpatient rehabilitation centers, hospice operations, home health agencies, behavioral health providers, ambulatory surgery centers, and urgent care facilities. This diversification across service lines reflects private equity's strategic use of joint ventures to penetrate fragmented healthcare markets where traditional acquisition might trigger regulatory review or face community resistance. The PESP report explicitly notes that the 500+ facility count likely undercounts actual prevalence, as many joint ventures lack public disclosure requirements and remain identifiable only through targeted research.
The emergence of joint ventures as a primary private equity strategy in healthcare occurs within a context of heightened scrutiny of traditional acquisition models. Recent bankruptcies involving major private equity-backed health systems have prompted regulatory attention and policy discussions around financial risk concentration in healthcare. Joint ventures, by distributing risk and leveraging nonprofit governance structures, may face different regulatory pathways than pure private equity acquisitions, potentially allowing firms to achieve market expansion while operating in lower-visibility regulatory environments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.